VKTX – viking therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

VKTX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/1

04:23 am

vktx

Assessing Viking Therapeutics (VKTX) Valuation After Recent Share Price Recovery [Yahoo! Finance]

Medium Report

Assessing Viking Therapeutics (VKTX) Valuation After Recent Share Price Recovery [Yahoo! Finance]

Report

11/29

01:13 pm

vktx

Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating [Yahoo! Finance]

Medium Report

Viking Therapeutics (VKTX) VANQUISH-1 Trial Completes Early, H.C. Wainwright Retains Buy Rating [Yahoo! Finance]

Report

11/25

04:05 pm

vktx

Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference

Low Report

Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference

Report

11/25

05:21 am

vktx

Viking Therapeutics (VKTX) Balances Rising R&D Costs With Clinical Progress: Is the Risk Worth the Potential? [Yahoo! Finance]

Medium Report

Viking Therapeutics (VKTX) Balances Rising R&D Costs With Clinical Progress: Is the Risk Worth the Potential? [Yahoo! Finance]

Report

11/21

05:31 am

vktx

Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.

Low Report

Viking Therapeutics (NASDAQ:VKTX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.

Report

11/21

04:31 am

vktx

Viking Therapeutics, Up 62% Since August, Undercuts A Buy Zone Despite Key Win [Yahoo! Finance]

Low Report

Viking Therapeutics, Up 62% Since August, Undercuts A Buy Zone Despite Key Win [Yahoo! Finance]

Report

11/19

03:03 am

vktx

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735 [Yahoo! Finance]

Medium Report

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735 [Yahoo! Finance]

Report

11/19

02:55 am

vktx

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735

Medium Report

Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735

Report

Date

Time

Symbol

Company Name

Action

%Chg

10/22/2025

04:05 pm

vktx

viking therapeutics, inc.

MISS Report

8.0%

viking therapeutics, inc.

Report

7/23/2025

04:05 pm

vktx

viking therapeutics, inc.

MISS Report

0.9%

viking therapeutics, inc.

Report

4/23/2025

04:05 pm

vktx

viking therapeutics, inc.

MISS Report

-1.1%

viking therapeutics, inc.

Report

2/5/2025

04:05 pm

vktx

viking therapeutics, inc.

MISS Report

-6.7%

viking therapeutics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/12

08:08 am

Maintains

Buy

Canaccord Genuity

Medium

Report

-3.5%

Report

10/29

07:06 am

Initiates

Buy

Canaccord Genuity

Low

Report

-1.1%

Report

10/29

05:21 am

Initiates

BUY

CANACCORD

Low

Report

-2.6%

Report

10/25

07:13 am

Upgrades

Strong-Buy

B. Riley

Medium

Report

3.9%

Report

10/25

07:13 am

Upgrades

Strong-Buy

B. Riley

Medium

Report

3.9%

Report

10/24

09:26 am

Maintains

Overweight

JP Morgan

Low

Report

-1.3%

Report

10/23

09:13 am

Maintains

Overweight

Morgan Stanley

Low

Report

-1.9%

Report

10/23

09:13 am

Maintains

Overweight

Morgan Stanley

Low

Report

-1.9%

Report

Date

Time

Symbol

Headline

Impact

11/5

11:50 am

vktx

Form SCHEDULE 13G/A Viking Therapeutics, Filed by: FMR LLC

Low Report

Form SCHEDULE 13G/A Viking Therapeutics, Filed by: FMR LLC

Report

10/28

07:51 pm

vktx

Form 4 Viking Therapeutics, For: Oct 27 Filed by: Mancini Marianna

Low Report

Form 4 Viking Therapeutics, For: Oct 27 Filed by: Mancini Marianna

Report

10/28

07:49 pm

vktx

Form 4 Viking Therapeutics, For: Oct 27 Filed by: Lian Brian

Low Report

Form 4 Viking Therapeutics, For: Oct 27 Filed by: Lian Brian

Report

10/28

07:49 pm

vktx

Form 4 Viking Therapeutics, For: Oct 27 Filed by: Rowland Charles A Jr

Low Report

Form 4 Viking Therapeutics, For: Oct 27 Filed by: Rowland Charles A Jr

Report

10/28

07:48 pm

vktx

Form 4 Viking Therapeutics, For: Oct 27 Filed by: ZANTE GREG

Low Report

Form 4 Viking Therapeutics, For: Oct 27 Filed by: ZANTE GREG

Report

10/28

04:34 pm

vktx

Form 144 Viking Therapeutics, Filed by: ZANTE GREG

Low Report

Form 144 Viking Therapeutics, Filed by: ZANTE GREG

Report

10/28

04:32 pm

vktx

Form 144 Viking Therapeutics, Filed by: Mancini Marianna

Low Report

Form 144 Viking Therapeutics, Filed by: Mancini Marianna

Report

10/28

04:28 pm

vktx

Form 144 Viking Therapeutics, Filed by: Lian Brian

Low Report

Form 144 Viking Therapeutics, Filed by: Lian Brian

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.